Coegin Pharma AB announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was SEK 743,000 compared to SEK 3.361 million a year ago. Operating loss was SEK 46.276 million compared to SEK 13.084 million a year ago. Net loss was SEK 46.242 million compared to SEK 13.364 million a year ago. Basic loss per share from continuing operations was SEK 0.09 compared to SEK 3.56 a year ago.